Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared a post on LinkedIn about a recent article by Shuhei Fujita et al, published in Journal of Clinical Lipidology.
”Important news supporting what has been previously thought: The occurrence of MACE did not differ between patients with and without a percent change in
Lp(a) levels of greater than or equal to 20 percent after statin use. Our observations indicate that an increase in Lp(a) following the commencement of statins
may not necessarily attenuate the anti-atherosclerotic effect of LDL-C lowering in patients with CAD.”
Title: A greater than or equal to 20 percent Increase in Circulating Lp(a) after the Commencement of Statins, and Subsequent Risks of Atherosclerotic Cardiovascular Diseases in Patients with Coronary Artery Disease
Authors: Shuhei Fujita, Yu Kataoka, Naoto Kuyama, Stephen J. Nicholls, Kentaro Mitsui, Kota Murai, Takamasa Iwai, Kenichiro Sawada, Hideo Matama, Satoshi Honda, Masashi Fujino, Shuichi Yoneda, Fumiyuki Otsuka, Kensuke Takagi, Kazuhiro Nakao, Yasuhide Asaumi, Ken-ichi Tsujita, Teruo Noguchi
Find more posts featuring Thomas Dayspring on Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants